PM.20.029 – GENEtics in personalized Medicine And Prevention (GENE-MAP)
Route: Personalised medicine: the individual at the centre
cluster question: 081 How will our knowledge of genetics play a role in analysing, screening for, and treating diseases?
Genetics influences risk of every disease and response to interventions from birth onwards, can be easily and comprehensively measured, at […]
View the initiative
PM.20.056 – Optimal survival and quality of life in metastatic colorectal cancer with irinotecan dosing based on UGT1A1 genotype and gut microbiome enzyme activity including a dietary intervention
Route: Personalised medicine: the individual at the centre
cluster question: 095 How can we personalise health care, for example by using biomarkers?
Problem description: Irinotecan-based systemic therapy is one of the main chemotherapeutic agents used for metastatic colorectal cancer (mCRC). It can […]
View the initiative
